Clinical Conversations Podcast 280: MIS-C After COVID-19 in Adolescents — Can Vaccination Prevent It?

In Clinical Conversations, Dr. Laura Zambrano, Senior Epidemiologist on the CDC's COVID-19 Response Team, joins Joe Elia to discuss a study examining the effects of COVID-19 vaccination on multisystem inflammatory syndrome in children.

MIS-C is a serious consequence of COVID-19 infection. In the latest Clinical Conversations, Joe Elia talks with Dr. Laura Zambrano about a CDC investigation into whether vaccination in adolescents lessened the chances of that complication. It sure seemed to, given that fully 95% of cases occurred among the unvaccinated.

Do you want to be notified whenever there is a new Clinical Conversations post? Sign up to receive notifications by email by using the Subscribe box. Or follow Clinical Conversations where you usually get your podcasts.

Listen to the interview (running time: 16 minutes).

Want to see more from NEJM Journal Watch? Register here

Clinical Conversations Podcast 280: MIS-C After COVID-19 in Adolescents — Can Vaccination Prevent It?

Topics